Back
G1 Therapeutics Stock Predictions
Sponsored
GTHX
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
46
GTHX
G1 Therapeutics
Last Price:
7.16
Seasonality Move:
-14.81%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmG1 Therapeutics Stock Forecast
- Over the next 52 weeks, G1 Therapeutics has on average historically risen by 42.7% based on the past 7 years of stock performance.
- G1 Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
-
Is G1 Therapeutics Stock Undervalued?
The current G1 Therapeutics [GTHX] share price is $7.15. The Score for GTHX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal. - GTHX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will G1 Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, G1 Therapeutics has on average historically risen by 42.7% based on the past 7 years of stock performance.
G1 Therapeutics Stock Rating
Sell
46
G1 Therapeutics (GTHX)
is a Sell
Is G1 Therapeutics overpriced?
- G1 Therapeutics has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
G1 Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
g1therapeutics.com
52-Week Data
52-Week High:
7.19
52-Week Low:
1.08
Prediction Charts
Market Cap:
377.22M
Price in USD:
7.15
Volume:
0
Beta:
1.80
Technical Analysis
SMA50:
5.75
SMA100:
4.60
SMA200:
4.06
52-Wk Change:
379.87%
Stock Predictions
-
Is G1 Therapeutics stock public?
Yes, G1 Therapeutics is a publicly traded company. -
What is the G1 Therapeutics stock quote today?
The G1 Therapeutics stock price is 7.15 USD today. -
How to buy G1 Therapeutics stock online?
You can buy G1 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Aug-29 | 7.12 | 7.11 | 7.12 | 7.11 |
Aug-30 | 7.11 | 7.12 | 7.12 | 7.11 |
Sep-3 | 7.12 | 7.09 | 7.12 | 7.09 |
Sep-4 | 7.10 | 7.13 | 7.13 | 7.09 |
Sep-5 | 7.12 | 7.13 | 7.13 | 7.12 |
Sep-6 | 7.13 | 7.13 | 7.13 | 7.12 |
Sep-9 | 7.13 | 7.14 | 7.14 | 7.12 |
Sep-10 | 7.13 | 7.13 | 7.14 | 7.12 |
Sep-11 | 7.13 | 7.12 | 7.13 | 7.12 |
Sep-12 | 7.13 | 7.13 | 7.13 | 7.12 |
Sep-13 | 7.13 | 7.15 | 7.15 | 7.13 |
Sep-16 | 7.14 | 7.15 | 7.15 | 7.13 |
Sep-17 | 7.15 | 7.15 | 7.16 | 7.14 |
Sep-18 | 7.15 | 7.15 | 7.15 | 7.15 |
G1 Therapeutics Earnings
G1 Therapeutics Earnings Report: Per Share G1 Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
G1 Therapeutics Forecast Revenue Growth
G1 Therapeutics Stock Analysis: Historical quarterly revenues per share for G1 Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.08 per share, an increase this year of $0.54 per share, and an increase next year of $0.37 per share.
* G1 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.